Self-management Behaviors and Resilience Among Chronic Obstructive Pulmonary Disease Patients

July 12, 2022 updated by: Shin Kong Wu Ho-Su Memorial Hospital

The Relations of Resilience to Self-management Behaviors Among Patients With Chronic Obstructive Pulmonary Disease

This study conducted an assessment of the influencing factors and correlations that affect self-management behaviors and resilience in the COPD population.

Study Overview

Status

Completed

Conditions

Detailed Description

A total of 100 participants with COPD from a medical center in Northern Taiwan were recruited from February 2020 to January 2021 in this cross-sectional study. Each subject completed self-reported questionnaires through face-to-face interviews, including 20-item COPD Self-Management Scale (CSMS-20) and a 25-item Connor-Davidson Resilience Scale (CD-RISC-25). A multiple linear regression model was used to examine the relationship between the levels of self-management behavior and resilience, controlling for sociodemographic and clinical factors.

Study Type

Observational

Enrollment (Actual)

112

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei, Taiwan
        • Shin Kong Wu Ho-Su Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The age ranged from 39-90 years old for all the population. The proportions of BMI < 18.5 kg/m2, 18.5-24.9 kg/m2, and ≥ 24.9 kg/m2 were 8%, 58%, and 34%, respectively. Overall, only 14% of the COPD subjects were educated with a university degree or higher, which was associated with higher self-management scores compared to those educated with below university degree. Half of the subjects were former smokers.

Description

Inclusion Criteria:

The recruited participants have been diagnosed with COPD for at least a month by thoracic physicians based on the guidelines of the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

Exclusion Criteria:

Participants who were diagnosed with serious mental disorders, cancer, terminal illness, or end-stage diseases were excluded from this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Crossover
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Levels of COPD self-management behavior
Time Frame: 2020-02-01 to 2021-01-30
Each subject completed the self-reported 20-item COPD Self-Management Scale (CSMS-20) questionnaire through face-to-face interviews. The range of scores is from 20 to 100, with a higher score indicating better self-management behaviors.
2020-02-01 to 2021-01-30
Levels of COPD psychological resilience
Time Frame: 2020-02-01 to 2021-01-30
Each subject completed the 25-item Connor-Davidson Resilience Scale (CD-RISC-25) questionnaire through face-to-face interviews. The range of scores is from 0 to 100, with a higher score indicating better psychological resilience.
2020-02-01 to 2021-01-30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shin Kong Wu Ho-Su Memorial Hospital

Investigators

  • Study Chair: EN-MING CHANG, master, Respiratory therapist

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

January 30, 2021

Study Completion (Actual)

January 30, 2021

Study Registration Dates

First Submitted

June 27, 2022

First Submitted That Met QC Criteria

July 12, 2022

First Posted (Actual)

July 15, 2022

Study Record Updates

Last Update Posted (Actual)

July 15, 2022

Last Update Submitted That Met QC Criteria

July 12, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20191101R

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe